131 related articles for article (PubMed ID: 27747612)
21. Budget impact analysis of vaccination against Haemophilus influenzae type b as a part of a Pentavalent vaccine in the childhood immunization schedule of Iran.
Teimouri F; Kebriaeezadeh A; Zahraei SM; Gheiratian M; Nikfar S
Daru; 2017 Jan; 25(1):1. PubMed ID: 28088246
[TBL] [Abstract][Full Text] [Related]
22. Shaping markets to benefit global health - A 15-year history and lessons learned from the pentavalent vaccine market.
Malhame M; Baker E; Gandhi G; Jones A; Kalpaxis P; Iqbal R; Momeni Y; Nguyen A
Vaccine X; 2019 Aug; 2():100033. PubMed ID: 31384748
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of Haemophilus influenzae type b (Hib) vaccine introduction in the universal immunization schedule in Haryana State, India.
Gupta M; Prinja S; Kumar R; Kaur M
Health Policy Plan; 2013 Jan; 28(1):51-61. PubMed ID: 22407018
[TBL] [Abstract][Full Text] [Related]
24. "Reverse engineering" a formulary selection algorithm to determine the economic value of pentavalent and hexavalent combination vaccines.
Sewell EC; Jacobson SH; Weniger BG
Pediatr Infect Dis J; 2001 Nov; 20(11 Suppl):S45-56. PubMed ID: 11704724
[TBL] [Abstract][Full Text] [Related]
25. The Costs of Implementing Vaccination With the RTS,S Malaria Vaccine in Five Sub-Saharan African Countries.
Sicuri E; Yaya Bocoum F; Nonvignon J; Alonso S; Fakih B; Bonsu G; Kariuki S; Leeuwenkamp O; Munguambe K; Mrisho M; Were V; Sauboin C
MDM Policy Pract; 2019; 4(2):2381468319896280. PubMed ID: 31903424
[No Abstract] [Full Text] [Related]
26. Re-evaluating the cost and cost-effectiveness of rotavirus vaccination in Bangladesh, Ghana, and Malawi: A comparison of three rotavirus vaccines.
Pecenka C; Debellut F; Bar-Zeev N; Anwari P; Nonvignon J; Shamsuzzaman M; Clark A
Vaccine; 2018 Nov; 36(49):7472-7478. PubMed ID: 30420039
[TBL] [Abstract][Full Text] [Related]
27. The impact of an integrated electronic immunization registry and logistics management information system (EIR-eLMIS) on vaccine availability in three regions in Tanzania: A pre-post and time-series analysis.
Gilbert SS; Bulula N; Yohana E; Thompson J; Beylerian E; Werner L; Shearer JC
Vaccine; 2020 Jan; 38(3):562-569. PubMed ID: 31706808
[TBL] [Abstract][Full Text] [Related]
28. Vaccine wastage and cost saving after multi-dose vial policy implementation in Egypt: A success story.
Radwan NF; Abu-Sheasha GA; Bedwani RN; Yassine OG
Vaccine; 2021 Dec; 39(51):7457-7463. PubMed ID: 34772545
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of cost-effectiveness of live oral pentavalent reassortant rotavirus vaccine introduction in Ghana.
Abbott C; Tiede B; Armah G; Mahmoud A
Vaccine; 2012 Mar; 30(15):2582-7. PubMed ID: 22321664
[TBL] [Abstract][Full Text] [Related]
30. The costs of introducing a malaria vaccine through the expanded program on immunization in Tanzania.
Hutton G; Tediosi F
Am J Trop Med Hyg; 2006 Aug; 75(2 Suppl):119-30. PubMed ID: 16931823
[TBL] [Abstract][Full Text] [Related]
31. Safety, immune lot-to-lot consistency and non-inferiority of a fully liquid pentavalent DTwp-HepB-Hib vaccine in healthy Indian toddlers and infants.
Gandhi DJ; Dhaded SM; Ravi MD; Dubey AP; Kundu R; Lalwani SK; Chhatwal J; Mathew LG; Gupta M; Sharma SD; Bavdekar SB; Jayanth MV; Ravinuthala S; Sil A; Dhingra MS
Hum Vaccin Immunother; 2016 Apr; 12(4):946-54. PubMed ID: 26580093
[TBL] [Abstract][Full Text] [Related]
32. A fully liquid DTPw-HepB-Hib combination vaccine for booster vaccination of toddlers in El Salvador.
Suárez E; Asturias EJ; Hilbert AK; Herzog C; Aeberhard U; Spyr C
Rev Panam Salud Publica; 2010 Feb; 27(2):117-24. PubMed ID: 20339615
[TBL] [Abstract][Full Text] [Related]
33. Multi-dose vials versus single-dose vials for vaccination: perspectives from lower-middle income countries.
Basu S; Rustagi R
Hum Vaccin Immunother; 2022 Nov; 18(6):2059310. PubMed ID: 35416750
[TBL] [Abstract][Full Text] [Related]
34. Economic evaluation of Haemophilus influenzae type b vaccination in Moscow, Russian Federation.
Platonov AE; Griffiths UK; Voeykova MV; Platonova OV; Shakhanina IL; Chistyakova GG; Robertson SE;
Vaccine; 2006 Mar; 24(13):2367-76. PubMed ID: 16413949
[TBL] [Abstract][Full Text] [Related]
35. The value of tailoring vial sizes to populations and locations.
Wedlock PT; Mitgang EA; Haidari LA; Prosser W; Brown ST; Krudwig K; Siegmund SS; DePasse JV; Bakal J; Leonard J; Welling J; Steinglass R; Mwansa FD; Phiri G; Lee BY
Vaccine; 2019 Jan; 37(4):637-644. PubMed ID: 30578087
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B virus surface antigen and antibody markers in children at a major paediatric hospital after the pentavalent DTP-HBV-Hib vaccination.
Apiung T; Ndanu TA; Mingle JA; Sagoe KW
Ghana Med J; 2017 Mar; 51(1):13-19. PubMed ID: 28959067
[TBL] [Abstract][Full Text] [Related]
37. Adverse events following immunisation (AEFI) reports from the Zimbabwe expanded programme on immunisation (ZEPI): an analysis of spontaneous reports in Vigibase® from 1997 to 2017.
Masuka JT; Khoza S
BMC Public Health; 2019 Aug; 19(1):1166. PubMed ID: 31455314
[TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness of pneumococcal conjugate vaccination in Croatia.
Vučina VV; Filipović SK; Kožnjak N; Stamenić V; Clark AD; Mounaud B; Blau J; Hoestlandt C; Kaić B
Vaccine; 2015 May; 33 Suppl 1():A209-18. PubMed ID: 25919163
[TBL] [Abstract][Full Text] [Related]
39. Safety and immunogenicity of a toddler dose following an infant series of a hexavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b, hepatitis B vaccine administered concurrently or at separate visits with a heptavalent pneumococcal conjugate vaccine.
Halperin SA; Tapiéro B; Dionne M; Meekison W; Diaz-Mitoma F; Zickler P; Rubin E; Embree J; Bhuyan P; Lee A; Li M; Tomovici A
Pediatr Infect Dis J; 2014 Jan; 33(1):73-80. PubMed ID: 24346596
[TBL] [Abstract][Full Text] [Related]
40. Post-authorization safety surveillance of a liquid pentavalent vaccine in Guatemalan children.
Asturias EJ; Contreras-Roldan IL; Ram M; Garcia-Melgar AJ; Morales-Oquendo V; Hartman K; Rauscher M; Moulton LH; Halsey NA
Vaccine; 2013 Dec; 31(49):5909-14. PubMed ID: 24055354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
